Barrington raised the firm’s price target on Option Care Health to $40 from $38 and keeps an Outperform rating on the shares after the company’s Q2 top line and profitability results beat the firm’s and consensus estimates and FY24 revenue expectations were raised.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health sees FY24 revenue $4.75B-$4.85B, consensus $4.75B
- Option Care Health reports Q2 EPS 30c, consensus 27c
- OPCH Earnings this Week: How Will it Perform?
- Option Care Health initiated with an Outperform at JMP Securities
- Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call